miR-210-3p protects against osteoarthritis through inhibiting subchondral angiogenesis by targeting the expression of TGFBR1 and ID4.
Front Immunol
; 13: 982278, 2022.
Article
in En
| MEDLINE
| ID: mdl-36263050
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteoarthritis
/
MicroRNAs
/
Inhibitor of Differentiation Proteins
/
Receptor, Transforming Growth Factor-beta Type I
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Front Immunol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: